of prenatal diagnosis and in utero treatment are the mainstay of the Lim Lab.
The ability to diagnose congenital conditions prior to birth has led to an
opportunity to understand the natural history of these processes and provide
antenatal therapy to prevent devastating morbidities and even death. While much
of our focus is on risk stratification using prenatal evaluations and the
development of prognostic indicators, we are also actively investigating the
role of prenatal biomarkers that may provide insight into the development and
progression of these fetal anomalies. The advancement and innovation of
operative techniques can then be performed in animal models with translation
into patient use. Additionally, we have the advantage of having immediate and
long term follow-up of our patients, which allows us to assess associated
outcomes and the efficacy of all treatments. We provide multidisciplinary care
through divisional partnerships within our institution and are involved in
various multicenter collaborations. These relationships allow us to innovate
and provide the best possible outcomes to our patients.
To reach the lab or for more information, contact us.